IGM Biosciences CEO Fred Schwarzer's 2019 pay jumps 46% to $757K
IGM Biosciences reports 2019 executive compensation
By ExecPay News
Published: July 6, 2020
IGM Biosciences reported fiscal year 2019 executive compensation information on July 6, 2020.
In 2019, three executives at IGM Biosciences received on average a compensation package of $649K, a 49% increase compared to previous year.
Fred Schwarzer, Chief Executive Officer, received $757K in total, which increased by 46% compared to 2018. 57% of Schwarzer's compensation, or $428K, was in salary. Schwarzer also received $208K in non-equity incentive plan and $121K in option awards.
Bruce Keyt, Chief Scientific Officer, received a compensation package of $601K, which increased by 71% compared to previous year. 59% of the compensation package, or $357K, was in salary.
Misbah Tahir, Chief Financial Officer, earned $589K in 2019.